← Back to headlines



Google DeepMind's Demis Hassabis aims to automate drug design
Sir Demis Hassabis, the head of Google DeepMind, has expressed his ambition to automate the process of drug design. This initiative highlights the potential application of artificial intelligence in pharmaceutical research and development.
9 Apr, 13:08 — 9 Apr, 13:08
Sources
Showing 1 of 1 sources
Related Stories

Bill Gates Warns of Widespread AI Job Losses and Urges Global Cooperation
34m ago
Musk and Zelensky Clash Over Ukraine Aid Strategy Amid Shifting Dynamics
34m ago

Nvidia Surges After Reporting Strong Earnings and Optimistic AI Outlook
34m ago

Meta Agrees to $17 Billion Settlement Over Teen Social Media Harm
45m ago